$927.89
109.1213.33%
Dern. MÀJ: Oct 30, 4:44 PM
Regeneron Pharmaceuticals (REGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $15.75 | $10.34 | $8.38 | $9.69 |
| Actual | $20.07 | $14.29 | $9.47 | $11.44 |
| Surprise | +27.4% | +38.2% | +13.0% | +18.1% |
| Revenue | ||||
| Estimate | $4.56B | $3.81B | $3.47B | $3.80B |
| Actual | $5.12B | $4.29B | $3.60B | $3.88B |
| Surprise | +12.2% | +12.5% | +3.75% | +2.27% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $19.91 | $10.66 | $12.47 | $13.72 |
| Revenue | ||||
| Consensus | $5.26B | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $20.07 | $15.75 | 27.4 % |
| Q2 | Jul 30, 2026 | $14.29 | $10.34 | 38.2 % |
| Q1 | Apr 29, 2026 | $9.47 | $8.38 | 13.0 % |
| Q4 | Jan 30, 2026 | $11.44 | $9.69 | 18.1 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $5.12B | $4.56B | 12.2 % |
| Q2 | Jul 30, 2026 | $4.29B | $3.81B | 12.5 % |
| Q1 | Apr 29, 2026 | $3.61B | $3.47B | 3.75 % |
| Q4 | Jan 30, 2026 | $3.88B | $3.80B | 2.27 % |